Cargando…

Intravenous ketamine and progressive cholangiopathy in COVID-19 patients

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893247/ https://www.ncbi.nlm.nih.gov/pubmed/33617925 http://dx.doi.org/10.1016/j.jhep.2021.02.007

Ejemplares similares

Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered
por: Deltenre, Pierre, et al.
Publicado: (2021)

Reply to: “Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered”
por: Mallet, Vincent
Publicado: (2021)

Billiary casts in post-COVID-19 cholangiopathy()
por: Soldera, Jonathan, et al.
Publicado: (2023)

Billiary casts in post-COVID-19 cholangiopathy()
por: Soldera, Jonathan, et al.
Publicado: (2023)

Ketamine-induced cholangiopathy in ARDS patients
por: de Tymowski, Christian, et al.
Publicado: (2021)

Post-COVID-19 Cholangiopathy: A Recent Indication for Liver Transplantation
por: Mansour, Subhi, et al.
Publicado: (2023)

A rare case of eosinophilic cholangiopathy
por: Li, Wenya, et al.
Publicado: (2020)

Persistent Ketamine-Induced Cholangiopathy: An Approach to Management
por: Nyirenda, Tiwonge J, et al.
Publicado: (2020)

As an analgesic ketamine versus fentanyl for total intravenous anesthesia
por: Ezici, Musa, et al.
Publicado: (2013)

Severe Ketamine-Induced Uropathy Associated With Cholangiopathy Requiring Percutaneous Nephrostomy
por: Manongi, Ngoda, et al.
Publicado: (2022)

Ketamine use in the COVID-19 era: be cautious!
por: Suri, Aditi, et al.
Publicado: (2020)

Comparison of dexmedetomidine and ketamine for the analgesic effect using intravenous patient-controlled analgesia after gynecological abdominal surgery
por: Lee, Wonjin, et al.
Publicado: (2013)

Post-COVID-19 cholangiopathy: Systematic review
por: Rasheed, Mazen Abdalla, et al.
Publicado: (2023)

Recurrent episodes of intractable laryngospasm followed by laryngeal and pulmonary oedema during dissociative anaesthesia with intravenous ketamine
por: Baduni, Neha, et al.
Publicado: (2010)

Post COVID-19 cholangiopathy – A deep dive
por: Bethineedi, Lakshmi Deepak, et al.
Publicado: (2021)

Critical Illness Cholangiopathy in COVID-19 Long-haulers
por: Saleem, Nasir, et al.
Publicado: (2022)

CRITICAL ILLNESS CHOLANGIOPATHY IN COVID-19 LONG-HAULERS
por: Saleem, Nasir, et al.
Publicado: (2022)

Post-COVID-19 Cholangiopathy: A Systematic Review
por: Yanny, Beshoy, et al.
Publicado: (2023)

Post-COVID-19 Cholangiopathy: Clinical and Radiologic Findings
por: Kim, Hae Young, et al.
Publicado: (2023)

Cholangiopathy as part of post-COVID syndrome
por: Rojas, Manuel, et al.
Publicado: (2021)

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
por: Hashimoto, Kenji
Publicado: (2014)

Ketamine: A Convulsant?
por: Kurdi, Madhuri S., et al.
Publicado: (2017)

Post-COVID-19 cholangiopathy: Current understanding and management options
por: Veerankutty, Fadl H, et al.
Publicado: (2023)

Post-COVID cholangiopathy: A narrative review
por: Caballero-Alvarado, José, et al.
Publicado: (2023)

Post-COVID cholangiopathy: A narrative review
por: Caballero-Alvarado, José, et al.
Publicado: (2023)

Ketamine with Propofol for Endoscopic Procedures
por: Bhalotra, Anju Romina
Publicado: (2018)

IgG4 Cholangiopathy
por: Zen, Yoh, et al.
Publicado: (2012)

Tutorial Review for Understanding of Cholangiopathy
por: Nakanuma, Yasuni
Publicado: (2012)

Cholangiopathy: Genetics, Mechanism, and Pathology
por: Nakanuma, Yasuni, et al.
Publicado: (2012)

The Crucial Role of Cholangiocytes in Cholangiopathies
por: Park, Seon Mee
Publicado: (2012)

Progressive HIV-associated Cholangiopathy in an HIV Patient Treated with Combination Antiretroviral Therapy
por: Imai, Kazuo, et al.
Publicado: (2016)

Ketamine-induced QTc interval prolongation
por: Singh, Tejinder S. Swaran, et al.
Publicado: (2017)

Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19()
por: Sánchez Cadena, Abraham David, et al.
Publicado: (2021)

Consideration Needed for early Anticoagulation Following Intravenous tPA in Patients with COVID-19
por: Jimenez, Angelo, et al.
Publicado: (2021)

Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
por: Xie, Yun, et al.
Publicado: (2020)

Comment on: “Low-Dose Ketamine for Outpatient Hysteroscopy.”
por: Raghuraman, M.S.
Publicado: (2021)

Rapidly Progressive Portal Cavernoma Cholangiopathy in a Patient With Infeasible Decompressive Shunt Surgery
por: Nadinskaia, Maria Yu, et al.
Publicado: (2023)

Cholangiopathy with Respect to Biliary Innate Immunity
por: Harada, Kenichi, et al.
Publicado: (2012)

Cholangiopathies – Towards a molecular understanding
por: Tam, Paul K.H., et al.
Publicado: (2018)

Non-neoplastic cholangiopathies: an algorithmic approach
por: Zacarias, Marina Silva, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_orjp007ufees9o96gd4ukag76t